Nasal high-flow therapy (NHFT) during exercise in patients with cystic fibrosis (CF): a randomized crossover trial
G. Spoletini (Leeds (West Yorkshire), United Kingdom), R. Watson (Leeds (West Yorkshire), United Kingdom), K. Pollard (Leeds (West Yorkshire), United Kingdom), W. Lim (Leeds (West Yorkshire), United Kingdom), C. Etherington (Leeds (West Yorkshire), United Kingdom), I. Clifton (Leeds (West Yorkshire), United Kingdom), D. Peckham (Leeds (West Yorkshire), United Kingdom)
Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis
Disease area: -
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Spoletini (Leeds (West Yorkshire), United Kingdom), R. Watson (Leeds (West Yorkshire), United Kingdom), K. Pollard (Leeds (West Yorkshire), United Kingdom), W. Lim (Leeds (West Yorkshire), United Kingdom), C. Etherington (Leeds (West Yorkshire), United Kingdom), I. Clifton (Leeds (West Yorkshire), United Kingdom), D. Peckham (Leeds (West Yorkshire), United Kingdom). Nasal high-flow therapy (NHFT) during exercise in patients with cystic fibrosis (CF): a randomized crossover trial. 365
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Acute effects of supplemental oxygen therapy (SOT) using different nasal cannulas on walking capacity in patients with idiopathic pulmonary fibrosis (IPF) – a randomized cross-over trial Source: International Congress 2019 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2019
Effect of high-flow oxygen therapy on exercise tolerance in idiopathic pulmonary fibrosis: a randomized crossover trial. Source: Virtual Congress 2021 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2021
Acute effects of supplemental oxygen therapy using different nasal cannulas on walking capacity in patients with idiopathic pulmonary fibrosis: a randomised crossover trial Source: ERJ Open Res, 6 (3) 00197-2020; 10.1183/23120541.00197-2020 Year: 2020
Azithromycin for the treatment of cough in idiopathic pulmonary fibrosis: A randomized controlled cross-over pilot trial. Source: Virtual Congress 2020 – Chronic cough: only symptom or disease? Year: 2020
The effects of pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis- A randomised controlled trial Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2017
Acute effects of nasal high-flow during exercise in COPD patients after an exacerbation : a randomized controlled cross-over trial Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019
A randomised crossover trial of chest physiotherapy in non-cystic fibrosis bronchiectasis Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009
Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques (ACBT) versus a new device Source: Eur Respir J 2004; 24: Suppl. 48, 406s Year: 2004
Exercise training is beneficial in patients with non-cystic fibrosis bronchiectasis – A multi-centre, randomised controlled trial Source: Annual Congress 2012 - Exercise and physical activity: towards evidence-based benefits in different populations Year: 2012
A randomised crossover trial of chest physiotherapy in non-cystic fibrosis bronchiectasis Source: Eur Respir J 2009; 34: 1086-1092 Year: 2009
Home-based pulmonary rehabilitation in patients with bronchiectasis: a randomized controlled trial Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care Year: 2017
Domiciliary high-flow nasal cannula oxygen therapy for stable hypercapnic chronic obstructive pulmonary disease: a prospective, multicentre, randomised crossover trial Source: International Congress 2017 – New insights in chronic respiratory failure Year: 2017
Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial Source: Eur Respir J 2013; 42: 1622-1632 Year: 2013
A feasibility, randomised controlled trial of a complex breathlessness intervention in idiopathic pulmonary fibrosis (BREEZE-IPF): study protocol Source: ERJ Open Res, 5 (4) 00186-2019; 10.1183/23120541.00186-2019 Year: 2019
Airway clearance in bronchiectasis: a randomised crossover trial of ACBT versus TIRE Source: Eur Respir J 2003; 22: Suppl. 45, 238s Year: 2003
High flow nasal cannula during walking in severe COPD patients: a randomized controlled trial. Source: International Congress 2018 – Additional latest insights in pulmonary rehabilitation for chronic lung diseases Year: 2018
Heliox and alveolar oxygenation in patients with chronic obstructive pulmonary disease: a multicentre, randomised, crossover study Source: Eur Respir J 2004; 24: Suppl. 48, 243s Year: 2004
Resistive inspiratory manoeuvre as airway clearance technique in stable patients with cystic fibrosis: A randomised crossover trial Source: International Congress 2016 – Physiotherapy management of the ill but spontaneously-breathing adult patient Year: 2016
High-dose versus low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (the COLDSTER trial) Source: Eur Respir J, 59 (2) 2102930; 10.1183/13993003.02930-2021 Year: 2022
The effects of T-PEP on ventilation lung scan in patients with bronchiectasis: Protocol for a randomized controlled trial Source: Annual Congress 2010 - Respiratory muscle function and training in acute and chronic respiratory disease Year: 2010